CLSS-based assessment of alfa-adrenoceptor blockers for male LUTS (CLAM-STUDY)

INTERVENTION: Silodosin 8 mg dairy Tamsulosis 0.2 mg dairy CONDITION: male lower urinary tract symptoms, mLUTS PRIMARY OUTCOME: Results of treatment with silodosin or tamsulosin hydrochloride evaluated by variations in the new CLSS evaluation index (total score and category‐specific score). SECONDARY OUTCOME: I‐PSS, OABSS, Uroflowmetry, Residual urine volume, Prostate volume INCLUSION CRITERIA: Male patients with newly diagnosed LUTS according to the treatment algorithm of the Clinical Practice Guidelines for Male Lower Urinary Tract Symptoms